BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17909368)

  • 1. A simulation-based evaluation of methods to estimate the impact of an adverse event on hospital length of stay.
    Samore MH; Shen S; Greene T; Stoddard G; Sauer B; Shinogle J; Nebeker J; Harbarth S
    Med Care; 2007 Oct; 45(10 Supl 2):S108-15. PubMed ID: 17909368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of admission-day crowding on the length of stay of pediatric hospitalizations.
    Lorch SA; Millman AM; Zhang X; Even-Shoshan O; Silber JH
    Pediatrics; 2008 Apr; 121(4):e718-30. PubMed ID: 18381501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of time-dependent bias in proportional hazards modelling.
    Beyersmann J; Wolkewitz M; Schumacher M
    Stat Med; 2008 Dec; 27(30):6439-54. PubMed ID: 18837068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies.
    Yu M; Xie D; Wang X; Weiner MG; Tannen RL
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():60-8. PubMed ID: 22552981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing alternative models: log vs Cox proportional hazard?
    Basu A; Manning WG; Mullahy J
    Health Econ; 2004 Aug; 13(8):749-65. PubMed ID: 15322988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two commonly used methods for exposure-adverse events analysis: comparisons and evaluations.
    Duan JZ
    J Clin Pharmacol; 2009 May; 49(5):540-52. PubMed ID: 19318526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the results of Cox proportional hazards model and parametric models in the study of length of stay in a tertiary teaching hospital in Tehran, Iran.
    Ravangard R; Arab M; Rashidian A; Akbarisari A; Zare A; Zeraati H
    Acta Med Iran; 2011; 49(10):650-8. PubMed ID: 22071639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database.
    Moran JL; Bristow P; Solomon PJ; George C; Hart GK;
    Crit Care Med; 2008 Jan; 36(1):46-61. PubMed ID: 18090383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital characteristics associated with post-discharge suicide of severely depressed patients.
    Lin HC; Lee HC; Kuo NW; Chu CH
    J Affect Disord; 2008 Oct; 110(3):215-21. PubMed ID: 18321592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.
    Glanz JM; McClure DL; Xu S; Hambidge SJ; Lee M; Kolczak MS; Kleinman K; Mullooly JP; France EK
    J Clin Epidemiol; 2006 Aug; 59(8):808-18. PubMed ID: 16828674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of functional impairment after acute illness and mortality: one-year follow-up study.
    Baztán JJ; Gálvez CP; Socorro A
    Gerontology; 2009; 55(3):269-74. PubMed ID: 19141990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mediterranean age-comorbidity prognostic index for survival in dialysis populations.
    Fernandez Lucas M; Teruel JL; Zamora J; Lopez Mateos M; Rivera M; Ortuno J
    J Nephrol; 2007; 20(6):696-702. PubMed ID: 18046672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods.
    Martens EP; de Boer A; Pestman WR; Belitser SV; Stricker BH; Klungel OH
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):1-8. PubMed ID: 17960554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting treatment-effect estimates with heterogeneity and choice: simulation model results.
    Brooks JM; Fang G
    Clin Ther; 2009 Apr; 31(4):902-19. PubMed ID: 19446162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple G-computation algorithm to quantify the causal effect of a secondary illness on the progression of a chronic disease.
    van der Wal WM; Prins M; Lumbreras B; Geskus RB
    Stat Med; 2009 Aug; 28(18):2325-37. PubMed ID: 19499549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dealing with competing risks: testing covariates and calculating sample size.
    Pintilie M
    Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies.
    van der Net JB; Janssens AC; Eijkemans MJ; Kastelein JJ; Sijbrands EJ; Steyerberg EW
    Eur J Hum Genet; 2008 Sep; 16(9):1111-6. PubMed ID: 18382476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.